Stay updated on Nivolumab ± Ipilimumab in Gastrointestinal Stromal Tumor Clinical Trial
Sign up to get notified when there's something new on the Nivolumab ± Ipilimumab in Gastrointestinal Stromal Tumor Clinical Trial page.

Latest updates to the Nivolumab ± Ipilimumab in Gastrointestinal Stromal Tumor Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded a Locations section with California as a location. Page revision updated to v3.3.3.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedThe government operating status notice has been removed from the page; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check62 days agoChange DetectedOnly minor formatting and metadata updates are visible; core study details remain unchanged.SummaryDifference0.4%

- Check91 days agoChange Detected- Added a government-operating-status notice and a link to official sources, indicating current operational context. - Updated version from v3.1.0 to v3.2.0, reflecting an upgrade.SummaryDifference3%

- Check98 days agoChange DetectedMajor update: expanded immune biology terminology and a version upgrade to v3.1.0, replacing v3.0.2.SummaryDifference1.0%

Stay in the know with updates to Nivolumab ± Ipilimumab in Gastrointestinal Stromal Tumor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab ± Ipilimumab in Gastrointestinal Stromal Tumor Clinical Trial page.